Compounds > venlafaxine hydrochloride
Page last updated: 2024-08-24

venlafaxine hydrochloride and Obesity

venlafaxine hydrochloride has been researched along with Obesity in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (16.67)18.2507
2000's5 (83.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brown, L; Eliasziw, M; Lavorato, DH; McLaren, L; Patten, SB; Williams, JV1
Brusman-Lovins, L; King, KH; Malhotra, S; McElroy, SL; Welge, JA1
Arguisola, MS; Tavakoli, SA1
Barbiroli, B; Bernardi, F; Cicognani, A; Lin, L; Lodi, R; Mignot, E; Montagna, P; Parmeggiani, A; Plazzi, G; Posar, A; Scano, MC; Tonon, C1
Heal, DJ; Hutchins, LJ; Jackson, HC; Mazurkiewicz, SE; Needham, AM1
Anghelescu, I; Himmerich, H; Klawe, C; Szegedi, A1

Trials

1 trial(s) available for venlafaxine hydrochloride and Obesity

ArticleYear
Venlafaxine treatment of binge-eating disorder associated with obesity: a series of 35 patients.
    The Journal of clinical psychiatry, 2002, Volume: 63, Issue:9

    Topics: Adult; Aged; Ambulatory Care; Antidepressive Agents, Second-Generation; Body Weight; Bulimia; Comorbidity; Cyclohexanols; Female; Humans; Middle Aged; Obesity; Psychiatric Status Rating Scales; Retrospective Studies; Severity of Illness Index; Treatment Outcome; Venlafaxine Hydrochloride

2002

Other Studies

5 other study(ies) available for venlafaxine hydrochloride and Obesity

ArticleYear
Major depression, antidepressant medication and the risk of obesity.
    Psychotherapy and psychosomatics, 2009, Volume: 78, Issue:3

    Topics: Adolescent; Adult; Aged; Antidepressive Agents; Body Mass Index; Cross-Sectional Studies; Cyclohexanols; Depressive Disorder, Major; Female; Humans; Incidence; Male; Middle Aged; Obesity; Risk Factors; Venlafaxine Hydrochloride; Young Adult

2009
Diabetic ketoacidosis in a patient treated with olanzapine, valproic acid, and venlafaxine.
    Southern medical journal, 2003, Volume: 96, Issue:7

    Topics: Adult; Anticonvulsants; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Cyclohexanols; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetic Ketoacidosis; Drug Interactions; Drug Therapy, Combination; Humans; Male; Obesity; Olanzapine; Pirenzepine; Risk Factors; Valproic Acid; Venlafaxine Hydrochloride

2003
Narcolepsy-cataplexy associated with precocious puberty.
    Neurology, 2006, May-23, Volume: 66, Issue:10

    Topics: Aspartic Acid; Benzhydryl Compounds; Cataplexy; Child; Creatine; Cyclohexanols; Disorders of Excessive Somnolence; Female; Hallucinations; Health Education; Humans; Hypothalamus; Intracellular Signaling Peptides and Proteins; Male; Modafinil; Narcolepsy; Neuropeptides; Night Terrors; Obesity; Orexins; Polysomnography; Puberty, Precocious; Television; Venlafaxine Hydrochloride

2006
Comparison of the effects of sibutramine and other monoamine reuptake inhibitors on food intake in the rat.
    British journal of pharmacology, 1997, Volume: 121, Issue:8

    Topics: Animals; Cyclobutanes; Cyclohexanols; Eating; Fenfluramine; Fluoxetine; Male; Neurotransmitter Uptake Inhibitors; Obesity; Rats; Rats, Sprague-Dawley; Venlafaxine Hydrochloride

1997
Topiramate in venlafaxine-induced visual hallucinations in an obese patient with a posterior cerebral artery infarction.
    Journal of clinical psychopharmacology, 2001, Volume: 21, Issue:4

    Topics: Agoraphobia; Alcoholism; Cyclohexanols; Depressive Disorder; Female; Fructose; Hallucinations; Humans; Infarction, Posterior Cerebral Artery; Middle Aged; Neuroprotective Agents; Obesity; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Topiramate; Venlafaxine Hydrochloride

2001